NYSEMKT: NSRX
Nasus Pharma Ltd Stock Ownership - Who owns Nasus Pharma?

Insider buying vs selling

Have Nasus Pharma Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Dan Benjamin TelemanChief Executive Officer2026-06-176,550$3.10
$20.31kBuy
Dan Benjamin TelemanChief Executive Officer2026-04-222,900$3.76
$10.90kBuy
Dan Benjamin TelemanChief Executive Officer2026-03-3115,000$2.04
$30.60kBuy

1 of 1

NSRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NSRX insiders and whales buy or sell their stock.

NSRX Shareholders

What type of owners hold Nasus Pharma Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Udi Gilboa21.35%1,924,476$6.97MInsider
Dalia Megiddo21.01%1,894,068$6.86MInsider
Ronnie Hershman14.85%1,338,463$4.85MInsider
Dan Benjamin Teleman1.81%163,541$592.02kInsider
Balyas0.01%898$3.25kInstitution
Cabcar0.01%616$2.23kInstitution
Velanc0.00%359$1.30kInstitution
Hudbay0.00%135$488.70Institution
Bleich0.00%90$325.80Institution
Citade0.00%22$79.64Institution

1 of 2

NSRX vs General Drug Manufacturer Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NSRX0.02%59.02%Net BuyingNet Buying
MIRA0.01%18.36%Net Buying
MDCX0.00%15.66%
SCLX0.00%100.00%Net Selling
AMRN0.00%15.85%Net SellingNet Selling

Nasus Pharma Stock Ownership FAQ

Who owns Nasus Pharma?

Nasus Pharma (NYSEMKT: NSRX) is owned by 0.02% institutional shareholders, 59.02% Nasus Pharma insiders, and 40.96% retail investors. Udi Gilboa is the largest individual Nasus Pharma shareholder, owning 1.92M shares representing 21.35% of the company. Udi Gilboa's Nasus Pharma shares are currently valued at $6.97M.

If you're new to stock investing, here's how to buy Nasus Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.